OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Toll‐like receptors in the pathogenesis of COVID‐19
Shaghayegh Khanmohammadi, Nima Rezaei
Journal of Medical Virology (2021) Vol. 93, Iss. 5, pp. 2735-2739
Open Access | Times Cited: 313

Showing 1-25 of 313 citing articles:

SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 679

The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 498

SARS-CoV-2, COVID-19 and the aging immune system
Juliet M. Bartleson, Dina Radenković, Anthony J. Covarrubias, et al.
Nature Aging (2021) Vol. 1, Iss. 9, pp. 769-782
Open Access | Times Cited: 276

Monocytes and Macrophages in COVID-19
Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 235

Pathogenesis and treatment of cytokine storm in COVID-19
Mehmet Soy, Gökhan Keser, Pamir Atagündüz
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 372-389
Open Access | Times Cited: 229

Host genetic factors determining COVID-19 susceptibility and severity
Thirumalaisamy P. Velavan, Srinivas Reddy Pallerla, Jule Rüter, et al.
EBioMedicine (2021) Vol. 72, pp. 103629-103629
Open Access | Times Cited: 182

TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection
Daria Bortolotti, Valentina Gentili, Sabrina Rizzo, et al.
Microorganisms (2021) Vol. 9, Iss. 9, pp. 1820-1820
Open Access | Times Cited: 155

Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Bin Wang, Lei Zhang, Yongqiang Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 150

A systematic review of pregnant women with COVID-19 and their neonates
Mona Mirbeyk, Amene Saghazadeh, Nima Rezaei
Archives of Gynecology and Obstetrics (2021)
Open Access | Times Cited: 130

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 118

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 62

Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 52

Toll‐like receptors in health and disease
Kunyu Wang, Hanyao Huang, Zhan Qi, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 21

Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis
Irene Pastis, Melody G. Santos, Akshita Paruchuri
Frontiers in Behavioral Neuroscience (2024) Vol. 17
Open Access | Times Cited: 18

Association of CNS demyelination and COVID-19 infection: an updated systematic review
Ismail Ibrahim Ismail, Sara Salama
Journal of Neurology (2021) Vol. 269, Iss. 2, pp. 541-576
Open Access | Times Cited: 94

Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús‐González, Carlos Daniel Cordero‐Rivera, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 88

SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3
Utkarsh Tripathi, Rayhane Nchioua, Larissa Prata, et al.
Aging (2021) Vol. 13, Iss. 18, pp. 21838-21854
Open Access | Times Cited: 68

Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 65

Immunosenescence and COVID-19
Jacek M. Witkowski, Tamás Fülöp, Ewa Bryl
Mechanisms of Ageing and Development (2022) Vol. 204, pp. 111672-111672
Open Access | Times Cited: 55

Toll-like receptors and metabolic (dysfunction)-associated fatty liver disease
Shaghayegh Khanmohammadi, Mohammad Shafi Kuchay
Pharmacological Research (2022) Vol. 185, pp. 106507-106507
Closed Access | Times Cited: 55

DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists
Ibtehaj A. Naqvi, Nicholas S. Giroux, Lyra B. Olson, et al.
Biomaterials (2022) Vol. 283, pp. 121393-121393
Open Access | Times Cited: 54

SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions
Rémi Planès, Jean-Baptiste Bert, Sofiane Tairi, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 999-999
Open Access | Times Cited: 43

Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42

Page 1 - Next Page

Scroll to top